The clinical manifestations (e.g., abdominal pain and fever) and imaging manifestations (e.g., appendiceal dilatation and wall thickening) of appendicitis after PD-1/PD-L1 inhibitors are similar to those of conventional appendicitis, so the current management strategies are largely similar (116). This evidence concerns the gene PDCD1 and appendicitis.